NCT03513367 The Validation Process for Confirmation of the French Version of the Pediatric Quality of Life Inventory :PedsQLTM. Status UNKNOWN Phase N/A
NCT03508947 Safety and Tolerability of WVE-210201 in Patients With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE1
NCT03507530 Effects of Fear of Falling on Physical Performance and Quality of Life in Children With Duchenne Muscular Dystrophy Status UNKNOWN Phase N/A
NCT03490214 Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography Status COMPLETED Phase NA
NCT03439670 A Study to Assess the Efficacy and Safety of Vamorolone in Boys With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE2
NCT03433807 Expanded Access Program for Idebenone in Participants With Duchenne Muscular Dystrophy (DMD) Status NO_LONGER_AVAILABLE Phase N/A
NCT03375164 A Gene Transfer Therapy Study to Evaluate the Safety of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE1/PHASE2
NCT03373968 Givinostat in Duchenne's Muscular Dystrophy Long-term Safety and Tolerability Study Status RECRUITING Phase PHASE2/PHASE3
NCT03368742 Microdystrophin Gene Transfer Study in Adolescents and Children With DMD Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03362502 A Study to Evaluate the Safety and Tolerability of PF-06939926 Gene Therapy in Duchenne Muscular Dystrophy Status TERMINATED Phase PHASE1
NCT03333590 Gene Transfer Clinical Trial to Deliver rAAVrh74.MCK.GALGT2 for Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE1/PHASE2
NCT03319030 Aerobic Exercise in Boys With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase N/A
NCT03218995 Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping Status COMPLETED Phase PHASE2
NCT03167255 Extension Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD) Status COMPLETED Phase PHASE2
NCT03067831 Bone Marrow-Derived Autologous Stem Cells for the Treatment of Duchenne Muscular Dystrophy Status UNKNOWN Phase PHASE1/PHASE2